secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001104659-23-063143
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics receives Nasdaq deficiency notice for negative stockholders' equity
--------------------------------------------------------------------------------

- Nasdaq notified Avenue Therapeutics on May 19, 2023, of non-compliance with minimum $2.5M stockholders' equity requirement.
- Q1 2023 10-Q reported stockholders' equity of negative $2,157,000.
- Company has 45 days (until July 3, 2023) to submit a plan to regain compliance.
- No immediate effect on listing; stock continues trading on Nasdaq under ATXI.
- Company intends to submit compliance plan and take measures to regain compliance, but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923063143/0001104659-23-063143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923063143/tm2316427d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-063143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer